Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

Conditions

• Multiple Sclerosis

Interventions

• DRUG: Intrathecal MSC-NP injection

Sponsor

Tisch Multiple Sclerosis Research Center of New York